Getinge (OTCMKTS:GNGBY - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $21.56, but opened at $20.65. Getinge shares last traded at $20.65, with a volume of 7,780 shares trading hands.
Getinge Trading Up 0.9%
The company has a market cap of $5.62 billion, a price-to-earnings ratio of 23.98 and a beta of 1.10. The business's fifty day moving average price is $20.92 and its 200 day moving average price is $22.22. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.32 and a quick ratio of 0.86.
Getinge (OTCMKTS:GNGBY - Get Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $0.47 EPS for the quarter. The company had revenue of $1.08 billion for the quarter. Getinge had a net margin of 6.54% and a return on equity of 10.60%.
Getinge Company Profile
(
Get Free Report)
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company's offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge's solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company's product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Getinge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Getinge wasn't on the list.
While Getinge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.